SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XILLIX FDA APPROVED -- Ignore unavailable to you. Want to Upgrade?

To: hsg who wrote (443)7/19/1999 6:15:00 PM
From: Edward W. Richmond  Read Replies (1) | Respond to of 572
 
hsg, I am sure that Xillix doesn't have any hope of positive cash flow with its current Life-Ling or the next generation version. I gather that they see the GI as the device to have greater market penetration. With possibly 2 years for the GI to get to market, we won't likely see positive cash flow for 3 years, in my opinion.
Financially, we should be fine for the next 12 months of operation.
Regards, Ed


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News